Immunocore Holdings plc

IMCRStocksBiotechnologyUnited KingdomNasdaqUSD

Price

$29.54

Today

-0.1%

YTD

-14.4%

About

Immunocore Holdings PLC - ADR is a commercial-stage T cell receptor (TCR) biotechnology company. Operating worldwide, the company is engaged in utilising its TCR technology to develop treatments for various types of cancer, infectious diseases, and autoimmune conditions. Immunocore Holdings PLC works within the biotechnology sector in the specific field of T-cell receptor-based immunotherapies. Through its advanced ImmTAC (Immune mobilising monospecific TCR Against Cancer) technology, the company has a therapeutic focus on providing novel treatment options targeting multiple indications. Receive news and updates on the IMCR share price by adding this stock to your eToro watchlist.

Price chart

Closing price history for IMCR (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-18.55

P/S (TTM)3.51

P/B (TTM)3.65

Market cap$1.52B

Cap tierSmall-cap

Industry avg P/E-1.91

Profitability

Gross margin98.06%

EBIT margin-5.24%

Net margin-0.70%

ROE-4.47%

ROA-1.64%

Earnings & Revenue

Revenue (TTM)$430.01M

Revenue growth (1Y)+20.2%

EPS (TTM)-$0.56

Free cash flow$-41.41M

Total debt$434.96M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)0.73

Employees524

Next earnings5 Nov '26

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.